These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10583624)

  • 41. A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo.
    Barman KD; Khaitan BK; Verma KK
    Dermatol Surg; 2004 Jan; 30(1):49-53. PubMed ID: 14692927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of psoralen photochemotherapy for vitiligo.
    Chuan MT; Tsai YJ; Wu MC
    J Formos Med Assoc; 1999 May; 98(5):335-40. PubMed ID: 10420701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitiligo. Therapeutic advances.
    Jimbow K
    Dermatol Clin; 1998 Apr; 16(2):399-407. PubMed ID: 9589212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
    Sapam R; Agrawal S; Dhali TK
    Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
    Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
    Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals.
    De Jager ME; Van de Kerkhof PC; De Jong EM; Seyger MM
    J Dermatolog Treat; 2009; 20(5):254-8. PubMed ID: 19418330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of tacrolimus ointment in vitiligo alone or in combination therapy.
    Berti S; Buggiani G; Lotti T
    Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consensus on the treatment of vitiligo - Brazilian Society of Dermatology.
    Dellatorre G; Antelo DAP; Bedrikow RB; Cestari TF; Follador I; Ramos DG; Silva de Castro CC
    An Bras Dermatol; 2020; 95 Suppl 1(Suppl 1):70-82. PubMed ID: 33153826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
    Hossani-Madani A; Halder R
    G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
    Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
    Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of psoralen therapies obtained abroad in two children with Vitiligo.
    Bell KA; Saardi KM; Norton SA; Habeshian KA
    Pediatr Dermatol; 2020 Sep; 37(5):922-924. PubMed ID: 32749013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pattern of topical corticosteroid prescribing in the United States, 1989-1991.
    Stern RS
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):183-6. PubMed ID: 8708016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The practice guideline 'vitiligo'].
    Menke HE; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1976-81. PubMed ID: 17002186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.
    Ameen M; Exarchou V; Chu AC
    Br J Dermatol; 2001 Sep; 145(3):476-9. PubMed ID: 11531840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of topical corticosteroids prescriptions in children with asthma.
    Arabkhazaeli A; Vijverberg SJH; van der Lee M; van der Ent CK; Bruijnzeel-Koomen CA; de Bruin-Weller MS; Raaijmakers JA; Maitland-van der Zee AH
    Pediatr Dermatol; 2018 May; 35(3):378-383. PubMed ID: 29573273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced treatment modalities for vitiligo.
    Patel NS; Paghdal KV; Cohen GF
    Dermatol Surg; 2012 Mar; 38(3):381-91. PubMed ID: 22288899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.